Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
|Articles|January 1, 1997
Supplements and Featured Publications
- Managing Hypercholesterolemia and Coronary Heart Disease
- Volume 3
- Issue 1 Suppl
Participants
Advertisement
Articles in this issue
almost 30 years ago
MCO Decisions and Solutionsalmost 30 years ago
The Importance of Lipid Lowering and Other Risk Reduction Therapiesalmost 30 years ago
Matching Risks to Interventions: When to Treat, How to Treatalmost 30 years ago
CME Quizalmost 30 years ago
Bibliographyalmost 30 years ago
Goals and Objectivesalmost 30 years ago
Introductionalmost 30 years ago
Clinical Study Outcomes and the Benefits of Treating Hypercholesterolemiaalmost 30 years ago
Goals for Patient Treatmentalmost 30 years ago
Pharmacoeconomics: The Cost Effectiveness of Lipid ManagementAdvertisement
Related to this article
Machine learning prediction of procalcitonin positivity using inexpensive routine laboratory tests may reduce procalcitonin test volume and support diagnostic stewardship.
After Pennsylvania began rewarding Medicaid managed care plans for increasing well-child visits among Black infants, rates did not change significantly overall but varied by region.
Greater 340B activity—measured by county-level hospital child sites and contract pharmacy arrangements—was associated with significantly higher county-level total and out-of-pocket health care spending.
Advertisement
Advertisement
Trending on AJMC
1
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
2
How Plans, Clinicians Should Handle Gray-Market Retatrutide
3
FDA Approves Asundexian, First FXIa Inhibitor to Prevent Repeat Stroke
4
Early-Onset Cancers Often Found Late as Screening Gaps Persist
5